107596-31-6 Usage
Description
R-(-)-MecaMylaMine Hydrochloride, also known as the R-(+) enantiomer of Mecamylamine, is a noncompetitive neuronal nicotinic receptor modulator. It is a white solid with chemical properties that make it a valuable compound in various applications.
Uses
Used in Pharmaceutical Industry:
R-(-)-MecaMylaMine Hydrochloride is used as a noncompetitive neuronal nicotinic receptor modulator for its ability to regulate neuronal nicotinic receptors, which can have potential therapeutic effects on various neurological conditions.
Used in Research Applications:
In the field of research, R-(-)-MecaMylaMine Hydrochloride is used as a research chemical to study the effects of noncompetitive neuronal nicotinic receptor modulation on various biological processes and to develop new drugs targeting these receptors.
Used in Drug Development:
R-(-)-MecaMylaMine Hydrochloride is used as a starting material or intermediate in the development of new drugs that target neuronal nicotinic receptors, potentially leading to novel treatments for neurological disorders and other conditions.
Used in Quality Control:
As a reference standard, R-(-)-MecaMylaMine Hydrochloride is used in quality control processes to ensure the purity and potency of pharmaceutical products containing this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 107596-31-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,5,9 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 107596-31:
(8*1)+(7*0)+(6*7)+(5*5)+(4*9)+(3*6)+(2*3)+(1*1)=136
136 % 10 = 6
So 107596-31-6 is a valid CAS Registry Number.
107596-31-6Relevant articles and documents
A new synthesis and preliminary evaluation of some analogues of mecamylamine-a compound with anti-addiction properties
Mangan, David,McNabola, Neasa,Clark, Emily H.,Bermudez, Isabel,Wonnacott, Susan,Southern, J. Mike
, p. 10787 - 10798 (2016)
A new synthesis of mecamylamine-a known anti-hypertensive drug with anti-addictive properties is described. The new route allowed access to two novel analogues whose activity at two nicotinic acetylcholine receptor subtypes was assessed.
Alkylated bicycloalkaneamines for treatment of neurotoxic injury
-
, (2008/06/13)
Compounds, compositions and methods of treatment are described to control brain damage associated with anoxia or ischemia which typically follows such conditions as stroke, cardiac arrest or perinatal asphyxia. The treatment includes administration of an alkylated bicycloalkaneamine compound as an antagonist to inhibit excitotoxic actions at major neuronal exzcitatory amino acid receptor sites.
Fragmentation of optically active (1-phenylethyl)- and (1-naphthylethyl)ureas in refluxing alcohols: Easy preparation of optically active amines of high optical purity
Schonenberger,Brossi
, p. 1486 - 1497 (2007/10/02)
-
